DISHMAN CARBOGEN AMCIS
Back to Cashflow Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-102 Cr | ₹-22 Cr | ₹250 Cr | ₹130 Cr | ₹-11 Cr |
What is the latest Cash Flow from Financing Activities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-102 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹-11 Cr |
How is Cash Flow from Financing Activities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-102 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹250 Cr | 91.52 | |
| Mar2022 | ₹130 Cr | Positive | |
| Mar2021 | ₹-11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,951.0 Cr | 4.9% | 7.4% | -28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 4.9% |
7.4% |
-28.5% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses